We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+14.14%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$94.3B
AUM Growth
+$7.96B
(+9.2%)
Cap. Flow
-$2.37B
Cap. Flow
% of AUM
-2.52%
Top 10 Holdings %
Top 10 Hldgs %
12.56%
Holding
2,315
New
140
Increased
934
Reduced
1,002
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$335M |
| 2 |
Exelon
EXC
|
+$314M |
| 3 |
Procter & Gamble
PG
|
+$241M |
| 4 |
TripAdvisor
TRIP
|
+$208M |
| 5 |
Starbucks
SBUX
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$551M |
| 2 |
Target
TGT
|
+$514M |
| 3 |
CELG
Celgene Corp
CELG
|
+$495M |
| 4 |
Cigna
CI
|
+$369M |
| 5 |
Costco
COST
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.77% |
| 2 | Healthcare | 19.09% |
| 3 | Consumer Discretionary | 13.69% |
| 4 | Industrials | 9.28% |
| 5 | Financials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRNE
2151
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $52K | ﹤0.01% |
10,873
-147,623
| -93% | -$387K |
|
|
DRRX
2152
DELISTED
DURECT Corp
DRRX
| $42K | ﹤0.01% |
6,645
-10,570
| -61% | -$71.3K |
|
2153
Safe Bulkers
SB
$774M
| $41K | ﹤0.01% |
28,318
-22,675
| -44% | -$37.5K |
|
2154
iShares Russell 2000 ETF
IWM
$81.9B
| $35K | ﹤0.01% |
227
-315,421
| -100% | -$47.4M |
|
|
KA
2155
DELISTED
Kineta, Inc. Common Stock
KA
| $22K | ﹤0.01% |
+126
| New | +$61.7K |
|
|
EPE
2156
DELISTED
EP Energy Corporation
EPE
| $18K | ﹤0.01% |
70,527
-533,146
| -88% | -$353K |
|
|
AMR
2157
DELISTED
Alta Mesa Resources Inc
AMR
| $14K | ﹤0.01% |
+52,253
| New | +$39.5K |
|
2158
Immunic
IMUX
$195M
| $12K | ﹤0.01% |
153
-1,336
| -90% | -$117K |
|
2159
Novavax
NVAX
$1.31B
| $6K | ﹤0.01% |
586
-6,571
| -92% | -$207K |
|
2160
Applied Optoelectronics
AAOI
$11.5B
| – | – |
-34,514
| Closed | -$533K |
|
2161
Acacia Research
ACTG
$470M
| – | – |
-30,118
| Closed | -$90K |
|
2162
Autoliv
ALV
$9B
| – | – |
-52,524
| Closed | -$3.69M |
|
2163
AnaptysBio
ANAB
$1.68B
| – | – |
-4,442
| Closed | -$283K |
|
2164
Aptiv
APTV
$10.3B
| – | – |
-12,060
| Closed | -$743K |
|
2165
Algonquin Power & Utilities
AQN
$4.42B
| – | – |
-11,560
| Closed | -$116K |
|
2166
Ardmore Shipping
ASC
$683M
| – | – |
-11,360
| Closed | -$53K |
|
2167
Axogen
AXGN
$2.5B
| – | – |
-16,639
| Closed | -$340K |
|
2168
Bassett Furniture
BSET
$176M
| – | – |
-12,069
| Closed | -$242K |
|
2169
Conagra Brands
CAG
$7.23B
| – | – |
-1,079,342
| Closed | -$23.1M |
|
2170
Charter Communications
CHTR
$18.2B
| – | – |
-749
| Closed | -$213K |
|
|
CIVI
2171
DELISTED
Civitas Resources
CIVI
| – | – |
-79,915
| Closed | -$1.65M |
|
2172
Commercial Metals
CMC
$8.31B
| – | – |
-607,649
| Closed | -$9.73M |
|
2173
Cimpress
CMPR
$2.31B
| – | – |
-5,838
| Closed | -$604K |
|
2174
Collegium Pharmaceutical
COLL
$956M
| – | – |
-17,335
| Closed | -$298K |
|
|
CTLP
2175
DELISTED
Cantaloupe
CTLP
| – | – |
-30,103
| Closed | -$117K |
|
Similar funds
VGA
AQR Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, AQR Capital Management held 2,315 positions worth $94.3B, up 9.2% from $86.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q1 2019 filing shows 140 new, 934 increased, 1,002 reduced and 155 closed positions. Its largest new stake was Canopy Growth: 121,700 shares worth $52.7M. The largest sale was Walmart Inc, an estimated $551M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AQR Capital Management's largest Q1 2019 buy was Canopy Growth: 121,700 shares worth $52.7M.
- AQR Capital Management added most to Biogen in Q1 2019, an estimated $335M increase.
- AQR Capital Management's biggest Q1 2019 reduction was Walmart Inc, cutting an estimated $551M.
- AQR Capital Management fully exited Dun & Bradstreet in Q1 2019, selling an estimated $74.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $94.3B portfolio in Q1 2019.
- AQR Capital Management opened 140 new positions and closed 155 in Q1 2019.
- AQR Capital Management's portfolio value rose 9.2% quarter-over-quarter to $94.3B.
Based on AQR Capital Management's 13F filing for Q1 2019, filed 14 May 2019.